LivaNova PLC Goodwill, Impairment Loss
LivaNova PLC (LIVN) reported Goodwill, Impairment Loss of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GoodwillImpairmentLoss · last filed 2025-02-25
- LivaNova PLC goodwill, impairment loss for the quarter ending 2023-12-31 was $0.00.
- LivaNova PLC goodwill, impairment loss for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- LivaNova PLC goodwill, impairment loss for the quarter ending 2022-12-31 was $0.00.
- LivaNova PLC goodwill, impairment loss for the quarter ending 2022-09-30 was $129.40M.
- LivaNova PLC goodwill, impairment loss for fiscal 2024 was $0.00.
- LivaNova PLC goodwill, impairment loss for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- LivaNova PLC goodwill, impairment loss for fiscal 2022 was $129.40M.
- LivaNova PLC goodwill, impairment loss for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Goodwill, Impairment Loss | Goodwill, Impairment Loss 1 month | Goodwill, Impairment Loss 3 month | Goodwill, Impairment Loss 6 month | Goodwill, Impairment Loss 8 month | Goodwill, Impairment Loss 9 month | Goodwill, Impairment Loss 12 month | Goodwill, Impairment Loss 20 month | Goodwill, Impairment Loss 63 month | Goodwill, Impairment Loss 87 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-25 | |||||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 | |||||||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | ||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $129.40M derived: sum of 2 quarters · filed 2025-02-25 | $129.40M 10-K · filed 2025-02-25 | $193.10M 10-K · filed 2023-02-27 | ||||||
| 2022-09-30 | $129.40M 10-Q · filed 2023-11-01 | $129.40M 10-Q · filed 2023-11-01 | ||||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 derived: sum of 2 quarters · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 | |||||||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | ||||||||
| 2020-12-31 | $21.27M 10-K · filed 2023-02-27 | $63.70M 10-K · filed 2022-03-01 | ||||||||
| 2020-12-02 | $21.30M 10-K · filed 2023-02-27 | |||||||||
| 2019-12-31 | $42.40M 10-K · filed 2020-03-02 | $42.42M 10-K · filed 2022-03-01 | ||||||||
| 2019-11-30 | $42.40M 10-K · filed 2022-03-01 | |||||||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | |||||||||
| 2017-12-31 | $0.00 10-K · filed 2020-03-02 | |||||||||
| 2016-12-31 | $18.35M 10-K · filed 2019-03-18 | |||||||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-09 | |||||||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-01 | $0.00 10-K · filed 2018-02-28 | ||||||||
| 2015-04-24 | $0.00 10-K · filed 2018-02-28 | |||||||||
| 2014-04-25 | $0.00 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |